MYC oncogenes and human neoplastic disease CE Nesbit, JM Tersak, EV Prochownik Oncogene 18 (19), 3004-3016, 1999 | 1469 | 1999 |
Myc-induced T cell leukemia in transgenic zebrafish DM Langenau, D Traver, AA Ferrando, JL Kutok, JC Aster, JP Kanki, S Lin, ... Science 299 (5608), 887-890, 2003 | 678 | 2003 |
Low molecular weight inhibitors of Myc–Max interaction and function X Yin, C Giap, JS Lazo, EV Prochownik Oncogene 22 (40), 6151-6159, 2003 | 512 | 2003 |
Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. VM Dixit, S Green, V Sarma, LB Holzman, FW Wolf, K O'Rourke, PA Ward, ... Journal of Biological Chemistry 265 (5), 2973-2978, 1990 | 508 | 1990 |
Constitutive Expression of a c-myb cDNA Blocks Friend Murine Erythroleukemia Cell Differentiation MF Clarke, JF Kukowska-Latallo, E Westin, M Smith, EV Prochownik Molecular and cellular biology 8 (2), 884-892, 1988 | 410 | 1988 |
Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation EV Prochownik, J Kukowska Nature 322 (6082), 848-850, 1986 | 363 | 1986 |
c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. JJ Ryan, E Prochownik, CA Gottlieb, IJ Apel, R Merino, G Nunez, ... Proceedings of the National Academy of Sciences 91 (13), 5878-5882, 1994 | 312 | 1994 |
Differential interactions of Id proteins with basic-helix-loop-helix transcription factors K Langlands, X Yin, G Anand, EV Prochownik Journal of Biological Chemistry 272 (32), 19785-19793, 1997 | 304 | 1997 |
Mutation of the MXI1 gene in prostate cancer LR Eagle, X Yin, AR Brothman, BJ Williams, NB Atkin, EV Prochownik Nature genetics 9 (3), 249-255, 1995 | 279 | 1995 |
c-myc Antisense Transcripts Accelerate Differentiation and Inhibit G1 Progression in Murine Erythroleukemia Cells EV Prochownik, J Kukowska, C Rodgers Molecular and cellular biology 8 (9), 3683-3695, 1988 | 278 | 1988 |
Regulation of reactive oxygen species, DNA damage and c-Myc function by peroxiredoxin 1 RA Egler, E Fernandes, K Rothermund, S Sereika, N de Souza-Pinto, ... Oncogene 24 (54), 8038-8050, 2005 | 269 | 2005 |
Improved low molecular weight Myc-Max inhibitors H Wang, DI Hammoudeh, AV Follis, BE Reese, JS Lazo, SJ Metallo, ... Molecular cancer therapeutics 6 (9), 2399-2408, 2007 | 258 | 2007 |
Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc DI Hammoudeh, AV Follis, EV Prochownik, SJ Metallo Journal of the American Chemical Society 131 (21), 7390-7401, 2009 | 257 | 2009 |
C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells D Zhuang, S Mannava, V Grachtchouk, WH Tang, S Patil, JA Wawrzyniak, ... Oncogene 27 (52), 6623-6634, 2008 | 227 | 2008 |
Therapeutic targeting of Myc EV Prochownik, PK Vogt Genes & cancer 1 (6), 650-659, 2010 | 210 | 2010 |
Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules AV Follis, DI Hammoudeh, H Wang, EV Prochownik, SJ Metallo Chemistry & biology 15 (11), 1149-1155, 2008 | 210 | 2008 |
The role for Myc in coordinating glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism in normal and neoplastic tissues ES Goetzman, EV Prochownik Frontiers in endocrinology 9, 129, 2018 | 206 | 2018 |
Regulation of megakaryocyte phenotype in human erythroleukemia cells. MW Long, CH Heffner, JL Williams, C Peters, EV Prochownik The Journal of clinical investigation 85 (4), 1072-1084, 1990 | 201 | 1990 |
c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle H Wang, S Mannava, V Grachtchouk, D Zhuang, MS Soengas, ... Oncogene 27 (13), 1905-1915, 2008 | 197 | 2008 |
Small-molecule inhibitors of the Myc oncoprotein S Fletcher, EV Prochownik Biochimica Et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1849 (5), 525-543, 2015 | 188 | 2015 |